Hidradenitis

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content.…

Lori Solomon WEDNESDAY, June 14, 2023 (HealthDay News) -- Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter…

Imsidolimab (anti-IL-36 receptor antagonist) did not demonstrate improvement over placebo in the primary endpoint and key secondary endpointsImsidolimab was safe and well tolerated with no imsidolimab-related serious or severe adverse…

Aside from causing potentially disfiguring skin lesions, hidradenitis suppurativa (HS) has a devastating impact on patients' quality of life…

To clear the air from the outset, treating hidradenitis suppurativa (HS) has always been challenging. Many patients delay seeking treatment until…

More than twice as many patients with moderate or severe hidradenitis suppurativa (HS) responded to the interleukin (IL)-17 inhibitor bimekizumab…

Adalimumab (Humira) in addition to surgery for moderate to severe hidradenitis suppurativa (HS) significantly increased the rate of complete…

Clinicians and patients alike could make a strong case that diagnosis is the biggest challenge for hidradenitis suppurativa (HS); or more…

Los Angeles, July 14, 2021 (GLOBE NEWSWIRE) -- Hidradenitis Suppurativa Pipeline Landscape: Novel Emerging Therapies and Key Pharmaceutical Companies Reinvigorates the Pipeline Landscape The Hidradenitis Suppurativa pipeline landscape…